Squire Patton Boggs hired Philip Prowse and Jameel Tarmohamed as partners in its London-based financial services practice group. Joining from Stephenson Harwood along with associate Andrew Green, they will play an active role in bolstering
Tags :cn1
Swiss law firm Niederer Kraft Frey advised Spanish food distribution company Transgourmet Ibérica on its joint venture with fellow Iberian distributor Nudisco. The parties Active in the food distribution business for hotels, caterings, and
Simon Hohler (pictured) has been promoted to a partnership position by Zurich-based firm Thouvenin Rechtsanwälte. This decision follows a eight year time-span during which Hohler contributed to the firm’s cause between, and has
Advestra has acted as Swiss legal counsel to the initial purchasers and lenders in connection with the financing of Bain Capital’s acquisition of SO.MA.CI.S. and the subsequent acquisition of AT&
As of January 2025, Catrina Luchsinger Gähwiler (pictured) joined Barandun as a new partner, leaving MLL, where she was a partner. The profile Before joining Barandun, Catrina Luchsinger Gähwiler worked at MLL from 2007 to 2024,
Simon Lang (pictured left) and Ulrich Sauter (pictured right) have joined Zurich-based law firm Advoro as new partners. The profiles Simon Lang has joined Advoro’s corporate/M&A team in Zurich. He advises
Homburger advised Alchemy US on the renewal of its credit financings. The firm entered into a term loan credit agreement with HPS Investment as a term loan agent. The firm also entered into an asset-based
Netrics, a portfolio company of funds advised by Bregal Unternehmerkapital and one of the largest Swiss providers of cloud and modern workspace solutions, has entered into a partnership with Solify, a company specialising in Azure-centric
Homburger served as legal advisor to UBS Switzerland AG and other syndicate banks in connection with the financing of Deutsche Private Equity’s (DPE) acquisition of IMPAG Group. UBS acted as mandated lead arranger, underwriter,
On October 25, 2024, Homburger advised Molecular Partners, a clinical-stage biotechnology company, in the announcement of the pricing of an underwritten public offering. The offering consisted of 3,642,988 American Depositary Shares (ADSs), representing new shares, priced at $5.49 per
